Biotech industry.
FY12 appropriations process, including H.R. 2112 and various Continuing Resolutions: FDA funding issues and drug approval/review oversight process. Monitor tax and healthcare policy changes in Super Committee negotiations. Implementation of healthcare reform law. FDA Drug Approval and appeal oversight process.  Issues related to patient and physician choice in medical treatments.  PATIENTS Act (S.660)
BUD - Budget/Appropriations MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
SQUIRE PATTON BOGGS
2550 M STREET, NW, WASHINGTON, DC, 20037, US
KEVIN O'NEILL MANNY ROSSMAN (Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09) KEVIN O'NEILL MANNY ROSSMAN (Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09)
Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09 Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09